U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625683) titled 'Observational Study of SIROPSEDAL in Acute Cough' on May 27.
Brief Summary: This prospective, multicenter, observational post-market clinical follow-up study evaluates the performance and safety of SIROPSEDAL in children and adults with acute cough treated in routine clinical practice. Patients prescribed SIROPSEDAL independently of study participation will be followed for 7 +/- 1 days using patient-reported outcomes including a cough visual analog scale and the Cough Symptom Score.
Study Start Date: Oct. 15, 2026
Study Type: OBSERVATIONAL
Condition:
Acute Cough
Upper Respiratory Tract Infection
Common Cold
Recruitment Status: N...